OncoNano Medicine

View the org chart displaying its 12 main executives

Most searched biographies at OncoNano Medicine

• Kartik Krishnan, Chief Executive Officer and Director
• Brett Giroir, Chairman of the Board
• Yumin Qiu, Director

Popular executive movements at OncoNano Medicine

• Melissa Paoloni, who was Senior Vice President, Corporate and Strategic Development, is promoted to Executive Vice President and Chief Operating Officer  (posted on March 3 2024).
• Kartik Krishnan, who was President and Head of Research & Development, is promoted to Chief Executive Officer and Director  (posted on March 3 2024).
• Kartik Krishnan, who was Chief Medical Officer, is promoted to President and Head of Research & Development  (posted on November 7 2023).

Create your alert
to follow the executive moves at OncoNano Medicine.

OncoNano Medicine has 2,279 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and Adaptive Phage Therapeutics (United States (USA)).

Popular M&A news in Biotechnology

• Metsera has just announced a $290 Million fundraising (posted on April 23 2024).
• Histogen has filed for bankruptcy protection  (posted on April 19 2024).
• Bruker has announced the acquisition of NanoString Technologies  (posted on April 18 2024).

Popular contacts in Biotechnology

• Ali Behbahani - Non-Executive Director at Adaptimmune Therapeutics
• Vik Bajaj - Director at Interline Therapeutics
• Khalil Barrage - Interim Chairman of the Board at Sensorion

Learn more about the Biotechnology industry >

Press releases by OncoNano Medicine

• Press Releases Archives - OncoNano Medicine

Social media about OncoNano Medicine

• OncoNano Medicine on Wikipedia, Google News & Yahoo Finance
• OncoNano Medicine on LinkedIn, Twitter & YouTube

Contact by email its executives including Kartik Krishnan

Call OncoNano Medicine at +1 781...

View the org chart

Register to receive your alert

Report an error